144 related articles for article (PubMed ID: 5613110)
1. [The effect of heparin on the blood coagulation system in patients with thromboembolic disease of the retinal vessels].
Efetova TM
Oftalmol Zh; 1967; 22(4):258-61. PubMed ID: 5613110
[No Abstract] [Full Text] [Related]
2. [Prolonged ambulatory anticoagulant treatment of patients with thromboembolic lesions of the retinal vessels].
Efetova TM
Oftalmol Zh; 1968; 23(8):604-7. PubMed ID: 5747458
[No Abstract] [Full Text] [Related]
3. [Thromboembolic lesions of the retinal vessels].
Kondratskii VF
Oftalmol Zh; 1971; 26(6):461-2. PubMed ID: 4268326
[No Abstract] [Full Text] [Related]
4. Coagulation, anticoagulation and pancreatic carcinoma.
Nakchbandi IA; Löhr JM
Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):445-55. PubMed ID: 18594494
[TBL] [Abstract][Full Text] [Related]
5. [Thrombosamine-heparin in retinal vascular obliterations].
Antoine F; Mendelsohn P
Bull Soc Ophtalmol Fr; 1965; 65(7):627-30. PubMed ID: 5844754
[No Abstract] [Full Text] [Related]
6. Treatment of thrombosis of the central retinal vein with streptokinase.
den Ottolander GJ; Craandijk A
Thromb Diath Haemorrh; 1968 Dec; 20(3):415-9. PubMed ID: 5710463
[No Abstract] [Full Text] [Related]
7. [Evaluation of heparin therapy: sensitivity of the various methods].
Merino J; González-Boullosa R; Benet I; García-Conde J
Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979
[No Abstract] [Full Text] [Related]
8. [Use of calcium heparinate in anticoagulant therapy].
Vivien P; Allannic H; Loussouarn J; Turpin J
Therapie; 1971; 26(1):141-8. PubMed ID: 5554761
[No Abstract] [Full Text] [Related]
9. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh IB; Sin'kov SV; Klevko VA
Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
[No Abstract] [Full Text] [Related]
10. [Anticoagulant treatment with heparin].
Langer B; Wolosker M; Albers MT
Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
[No Abstract] [Full Text] [Related]
11. Recent advances in heparin structure, function and clinical usage.
Fussi F
Boll Chim Farm; 1978 Oct; 117(10):561-74. PubMed ID: 743352
[No Abstract] [Full Text] [Related]
12. [Inhibition of plasmatic coagulation: what is new?].
Schwarz M; Bode C
Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of thromboembolic complications in cancer patients].
Kapatsinskiĭ EV
Sov Med; 1983; (4):69-72. PubMed ID: 6867836
[No Abstract] [Full Text] [Related]
14. Sources of error in heparin therapy of thromboembolic disease.
Hattersley PG; Mitsuoka JC; King JH
Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615
[TBL] [Abstract][Full Text] [Related]
15. [Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent].
Cristau P; Hainaut J; Molinie C; Essioux H; Pariente A; Florent C; Laverdant C
Ann Med Interne (Paris); 1977 Nov; 128(11):887-94. PubMed ID: 563206
[No Abstract] [Full Text] [Related]
16. [Hypercoagulation and cancer. New treatment possibilities].
Lykke J; Nielsen HJ
Ugeskr Laeger; 2004 Aug; 166(33):2781-4. PubMed ID: 15344855
[No Abstract] [Full Text] [Related]
17. [Physico-chemical and quantitative studies of electrophoresis].
Ulashchik VS
Vopr Kurortol Fizioter Lech Fiz Kult; 1974; (5):296-401. PubMed ID: 4446421
[No Abstract] [Full Text] [Related]
18. Anticoagulation recidivans.
N Engl J Med; 1968 May; 278(22):1231-2. PubMed ID: 5647745
[No Abstract] [Full Text] [Related]
19. Low molecular weight heparins: the future of thromboembolic therapy.
Dobbin KR
Nurse Pract; 1998 Mar; 23(3):98,101-4,106-7. PubMed ID: 9560832
[No Abstract] [Full Text] [Related]
20. Implications of anticoagulant therapy.
Ellison N; Jobes DR; Schwartz AJ
Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
